Actively Recruiting
Turkish Chronic Lymphocytic Leukemia Study Group Registry - Multicenter Prospective Study
Led by Fatih Demirkan, MD · Updated on 2021-03-09
1000
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to collect detailed information on the history and real-world treatment of patients diagnosed with chronic lymphocytic leukemia (CLL) across multiple centers in Turkey. The study seeks to better understand how CLL is managed in both community and academic healthcare settings and to evaluate the effectiveness of first, second, and later treatment strategies used for this condition. As an observational study, it does not involve experimental treatments or interventions but instead gathers data from patients diagnosed with CLL. The study follows patients over time to observe the distribution of first-line therapy protocols within 36 months. This approach allows researchers to see how treatments are applied in everyday clinical practice and their outcomes. Participants will be involved through regular data collection regarding their diagnosis and treatment history. Researchers will review medical records and treatment patterns to assess therapy use and outcomes. The primary outcome measure focuses on the types of first-line therapy given over a three-year period. The study spans several years, starting in 2017 and continuing through at least August 2026.
CONDITIONS
Brief Title
Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed as CLL
- 18 years or older
- Able and willing to provide the written informed consent
You will not qualify if you...
- Younger than 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 36 months
Participants with chronic lymphocytic leukemia are observed to collect data on disease history, management, and treatment effectiveness in real-world settings.
Periodic visits as per routine care
Trial Site Locations
Total: 1 location
1
Dokuz Eylum Medical Favulty
Izmir, Turkey (Türkiye)
Actively Recruiting
Research Team
F
Fatih Demirkan, Prof
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here